Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson’s disease
Authors
- Mahmoud S. Abdallah (ORCID: https://orcid.org/0000-0002-3237-1792)
- Fedaa A. Kotkata (ORCID: https://orcid.org/0000-0002-0108-2517)
- Ramy M. El Sabaa
- Mohamed Yasser (ORCID: https://orcid.org/0000-0003-0206-0042)
- Muhammed M. Salahuddin (ORCID: https://orcid.org/0000-0001-7464-1706)
- Eman I. Elberri
- Yasmine Elmorsi (ORCID: https://orcid.org/0000-0002-5875-7597)
- Walaa A. Negm (ORCID: https://orcid.org/0000-0003-0463-8047)
- Amir O. Hamouda (ORCID: https://orcid.org/0000-0003-3604-0437)
- Manal A. Hamouda
- Thanaa A. El‐Masry
- Hayam Ali AlRasheed (ORCID: https://orcid.org/0009-0002-6186-848X)
- Khlood Mohammad Aldossary
- Nashwa Eltantawy
- Mostafa Kamel (ORCID: https://orcid.org/0000-0002-9754-4957)
- Mostafa M. Bahaa (ORCID: https://orcid.org/0000-0003-3332-4573)
- Mirna E. ElAwady
- Mamdouh Eldesouqui
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- Damietta University (EG)
- Sinai University (EG)
- Tanta University (EG)
- Jadara University (JO)
- University of Sadat City (EG)
- Arish University (EG)
- Menoufia University (EG)
- Egyptian Russian University (EG)
- Port Said University (EG)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.3389/fphar.2025.1497261
- Citations
- 6
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.34
Funders
- AlMaarefa University
- Princess Nourah Bint Abdulrahman University
- Tanta University